March 12th 2024
Medical spending on pediatric mental health conditions accounted for 46.6% of all pediatric medical spending in 2021.
February 5th 2024
Risks and Liabilities in Pharmacy Practice
1.0 Credit / Law
View More
Background and Key Concepts in Biosimilars: Improving Awareness and Addressing Common Concerns
1.0 Credit / Law
View More
Clinical Conversations With the Cancer Care Team: Striving for Equitable Access to Oral Anticancer Medications
1.5 Credits / Law, Oncology
View More
Child Abuse: Responsibilities and Protection of the Reporter
1.0 Credit / Law
View More
Stress Ulcer Prophylaxis May Not Prevent Gastrointestinal Bleeding in Neonates
December 4th 2023According to a poster presented at ASHP Midyear 2023, stress ulcer prophylaxis (SUP) did not increase adverse effects, suggesting limited preventive benefits for gastrointestinal bleeding (GIB) in neonates.
Navigating a Complicated Pediatric COVID-19 Case With Immunomodulatory Therapies
November 6th 2023A poster session at the 2023 American Academy of Pediatrics National Conference & Exhibition, featured a complex pediatric case involving SARS-CoV-2, bacterial coinfection, multiorgan failure, thrombotic microangiopathy, and systemic hyperinflammation.
Review of FDA Approvals for Pediatric Obesity Management
GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
Multiple Lisdexamfetamine Dimesylate Generics for ADHD in Children Approved by FDA
September 13th 2023In addition to approving these generics for children, adolescents and adults with ADHD, the generic chewable tablets and capsules are also approved for adults with moderate to severe binge-eating disorder.